AI Science Tracker
EN

Predicting Postoperative Lung Cancer Recurrence and Survival Using Cox Proportional Hazards Regression and Machine Learning

University of Pennsylvania · 26 Dec 2024 · medicine

Discovery

Predicting Postoperative Lung Cancer Recurrence and Survival Using Cox Proportional Hazards Regression and Machine Learning

Source check: Source checked. Not independent scientific confirmation.

Finding: Publisher full text read in Chrome, Methods and Results: retrospective cohort 309/512 NSCLC lung-resection patients; CT radiomic/body-composition features with Cox regression and ML (logistic/SVM among approaches), five-fold validation, AUC about .75–.77. Specific recurrence/survival association with no external cohort. Publisher also links a later comment/reply (Cancers 2025, 17(4), 697; 17(5), 727) critiquing limitations in variable interpretation; the reply acknowledges the issue and plans alternative approaches, which qualifies causal/mechanistic interpretation but does not negate the reported predictive association. This record is limited to the study result and does not establish independent replication or real-world benefit.

Technology: Logistic regression and SVM

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Publisher full text read in Chrome, Methods and Results: retrospective cohort 309/512 NSCLC lung-resection patients; CT radiomic/body-composition features with Cox regression and ML (logistic/SVM among approaches), five-fold validation, AUC about .75–.77. Specific recurrence/survival association with no external cohort. Publisher also links a later comment/reply (Cancers 2025, 17(4), 697; 17(5), 727) critiquing limitations in variable interpretation; the reply acknowledges the issue and plans alternative approaches, which qualifies causal/mechanistic interpretation but does not negate the reported predictive association.
Test and result
Publisher full text read in Chrome, Methods and Results: retrospective cohort 309/512 NSCLC lung-resection patients; CT radiomic/body-composition features with Cox regression and ML (logistic/SVM among approaches), five-fold validation, AUC about .75–.77. Specific recurrence/survival association with no external cohort. Publisher also links a later comment/reply (Cancers 2025, 17(4), 697; 17(5), 727) critiquing limitations in variable interpretation; the reply acknowledges the issue and plans alternative approaches, which qualifies causal/mechanistic interpretation but does not negate the reported predictive association.
Limitation / still unknown
No prospective clinical benefit or broader external validity is established by the documented study.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.mdpi.com/2072-6694/17/1/33

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.